Drug Type Small molecule drug |
Synonyms Fotagliptin, Futagliptin benzoic acid, FCN-005 + [1] |
Target |
Mechanism DPP-4 inhibitors(Dipeptidyl peptidase IV inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhaseNDA/BLA |
First Approval Date- |
RegulationPriority Review (CN) |
Molecular FormulaC24H25FN6O3 |
InChIKeyCEIKPTLXEHWGMB-XFULWGLBSA-N |
CAS Registry1403496-40-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | NDA/BLA | CN | 10 Feb 2023 | |
Renal Insufficiency | Phase 1 | CN | 15 Mar 2022 | |
Renal Insufficiency | Phase 1 | CN | 15 Mar 2022 |
Phase 3 | - | aogqnycebt(ntmybnwnfd) = biqglcvmwg wymyteohyd (vmcjeytleu ) View more | Positive | 09 Oct 2023 | |||
aogqnycebt(ntmybnwnfd) = upjtedqqpz wymyteohyd (vmcjeytleu ) View more |